Momentum - Spring 2012

ADVERTISEMENT
For over 22 years, Bayer®
< < < from our first clinical trial to
1988
1993
1995
2001

Clinical Trial
The 1st BETASERON®
clinical trial begins
(372 participants)

FDA Approval
The 1st disease-modifying
therapy approved to
treat RRMS

MS Pathways
The 1st MS patient
support program, now
called BETAPLUS®

BETA Nurse
Support
The 1st support program
to offer 24/7/365
MS-trained nurses

Now and for the road ahead: experience, tools and support for people with RRMS.

INDICATIONS AND USAGE BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

If you and your doctor are considering therapy for relapsing-remitting MS (RRMS), ask if BETASERON (interferon beta-1b) may be right for you. BETASERON is an effective therapy used by thousands of people with relapsing forms of MS to reduce the frequency of flare-ups.

• BETASERON has been shown to help delay the progression to clinically definite MS (CDMS) when used from the first signs of MS1

• BETAPLUS, a FREE support program, includes 24/7/365 access to an MS-trained BETA Nurse

• Bayer offers $0 monthly copay to help make treatment more affordable*

To learn more about BETASERON and BETAPLUS, call 1-800-788-1467 or visit www.BETASERON.com.

IMPORTANT SAFETY INFORMATION

• BETASERON should be used with caution in patients with depression.

• Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites.

• Severe hepatic injury, including cases of hepatic failure, has been reported. Patients should be monitored for liver enzyme elevations while taking BETASERON.

• BETASERON should be used with caution in patients with seizure disorders or cardiac disease.

iPhone is a trademark of Apple Inc. BETASERON, Bayer, the Bayer cross and BE TAPLUS are registered trademarks of Bayer. myBETAapp is a trademark of Bayer.